Civic Intelligence

Oxfendazole Development Group

990 • Fiscal year 2017 • EIN 81-1547477

Jan 01, 2017 to Dec 31, 2017

Organization Profilehttps: oxfendazoledevelopmentgroup.org
Blue Bell, PA
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

97th percentile

1.79x

Higher debt load relative to assets than 97% of similar nonprofits.

2017 filings • 501(c)3 • <$500k nonprofits • Source year 2017

Liabilities / Revenue

86th percentile

0.18x

Higher debt load relative to revenue than 86% of similar nonprofits.

2017 filings • 501(c)3 • <$500k nonprofits • Source year 2017

Net Margin

56th percentile

5.7%

Higher net margin than 56% of similar nonprofits.

2017 filings • 501(c)3 • <$500k nonprofits • Source year 2017

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2017

Asset Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2017

Revenue Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2017

Balance Sheet
Liabilities / Assets97th percentile

Assets

$9,766

No earlier filing loaded for comparison.

Net Assets

-$7,760

No earlier filing loaded for comparison.

Liabilities

$17,527

No earlier filing loaded for comparison.

Revenue And Expenses
Liabilities / Revenue86th percentileNet Margin56th percentile

Revenue

$97,653

No earlier filing loaded for comparison.

Expenses

$92,121

No earlier filing loaded for comparison.

Net Income

$5,532

No earlier filing loaded for comparison.

Historical Trend

Balance Sheet Trend

Asset GrowthScore unavailable

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$2.0M$1.5M$1.0M$500K$0-$500KAssets 2017: $9,766Liabilities 2017: $17,527Net Assets 2017: -$7,7602017Assets 2018: $4,995Liabilities 2018: $17,527Net Assets 2018: -$12,5322018Assets 2022: $1,721,909Liabilities 2022: $17,527Net Assets 2022: $1,704,3822022Assets 2023: $1,146,889Liabilities 2023: $0Net Assets 2023: $1,146,8892023

Highlighted filing

2017

Assets$9,766
Liabilities$17,527
Net Assets-$7,760
Open 2017 Filing

Operations Trend

Revenue GrowthScore unavailable

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$2.0M$1.0M$0-$1.0MRevenue 2017: $97,653Expenses 2017: $92,121Net Income 2017: $5,5322017Revenue 2018: $9,233Expenses 2018: $14,004Net Income 2018: -$4,7712018Revenue 2022: $1,710,127Expenses 2022: $42,614Net Income 2022: $1,667,5132022Revenue 2023: $58,517Expenses 2023: $604,664Net Income 2023: -$546,1472023

Highlighted filing

2017

Revenue$97,653
Expenses$92,121
Net Income$5,532
Open 2017 Filing
Filing Detail Status

This 2017 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

View Latest Detailed Filing (2025)
Jump To
Filing Snapshot
Filing Period
Jan 1, 2017 to Dec 31, 2017
Mission and Program Overview

Mission

The Oxfendazole Development Group is a 501c3 nonprofit organization formed and operated exclusively for charitable purposes specifically for the purpose of engaging in research and development of pharmaceutical treatments to help eliminate neglected tropical diseases NTDs and to facilitate access to such treatments for individuals in need.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2017 • Form 990Summary only. Only limited summary data is available for this year.

Open filing
Assets
$9,766
Liabilities
$17,527
Net assets
-$7,760
Revenue
$97,653
Expenses
$92,121
Net income
$5,532
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2023Summary only. Only limited summary data is available for this year.$1.15$0.00$1.15$0.06$0.60$0.55
2022Facts available. Structured filing facts are available, but richer extracted sections are limited.$1.72$0.02$1.70$1.71$0.04$1.67
2018Summary only. Only limited summary data is available for this year.$0.00$0.02$0.01$0.01$0.01$0.00
2017Summary only. Only limited summary data is available for this year.$0.01$0.02$0.01$0.10$0.09$0.01